HLA
Hamilton Lane Advisors’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,861
| Closed | -$251K | – | 86 |
|
|
2021
Q2 | $251K | Sell |
11,861
-9,392
| -44% | -$199K | 0.08% | 70 |
|
|
2021
Q1 | $596K | Sell |
21,253
-24,928
| -54% | -$699K | 0.19% | 54 |
|
|
2020
Q4 | $1.2M | Hold |
46,181
| – | – | 0.45% | 31 |
|
|
2020
Q3 | $1.72M | Hold |
46,181
| – | – | 0.83% | 22 |
|
|
2020
Q2 | $2.37M | Hold |
46,181
| – | – | 1.27% | 16 |
|
|
2020
Q1 | $1.46M | Sell |
46,181
-6,645
| -13% | -$210K | 0.84% | 21 |
|
|
2019
Q4 | $3.15M | Hold |
52,826
| – | – | 1.38% | 17 |
|
|
2019
Q3 | $1.94M | Hold |
52,826
| – | – | 0.81% | 23 |
|
|
2019
Q2 | $2.46M | Hold |
52,826
| – | – | 1.22% | 15 |
|
|
2019
Q1 | $2.12M | Buy |
52,826
+31,264
| +145% | +$1.26M | 1.12% | 20 |
|
|
2018
Q4 | $992K | Hold |
21,562
| – | – | 0.87% | 24 |
|
|
2018
Q3 | $1K | Hold |
21,562
| – | – | 0.41% | 30 |
|
|
2018
Q2 | $1K | Sell |
21,562
-10,000
| -32% | -$464 | 0.91% | 27 |
|
|
2018
Q1 | $2K | Sell |
31,562
-83,782
| -73% | -$5.31K | 1.59% | 18 |
|
|
2017
Q4 | $7.59M | Buy |
+115,344
| New | +$7.59M | 3.92% | 6 |
|
|
2015
Q3 | – | Sell |
-23,847
| Closed | -$1.95M | – | 53 |
|
|
2015
Q2 | $1.95M | Buy |
23,847
+19,091
| +401% | +$1.56M | 0.74% | 28 |
|
|
2015
Q1 | $440K | Buy |
+4,756
| New | +$440K | 0.2% | 39 |
|